Loading...
HomeMy WebLinkAboutMINUTES - 11032015 - C.74RECOMMENDATION(S): Approve and authorize the Purchasing Agent on behalf, of the Health Services Department, to execute a Purchase Order with Polymedco Cancer Diagnostic Products, LLC., in the amount of $120,000 to purchase reagents and supplies to perform immunochemical fecal occult blood testing for the Clinical Laboratory at Contra Costa Regional Medical Center (CCRMC), for the period October 1, 2015 through September 31, 2016. FISCAL IMPACT: 100% funding is included in the Hospital Enterprise Fund I Budget. BACKGROUND: Polymedco’s OC-Auto Micro 80 Analyzer with FOBT-CHECKoc reagents is an automated immunochemical fecal occult blood testing system that detects human red cells only with no interferences from red meat, turnips, melons, aspirin, anti-inflammatory drugs and vitamin C. This improvement directs many more of the “right” patients to colonoscopy leading to the earlier detection of polyps and colorectal cancer. CONSEQUENCE OF NEGATIVE ACTION: If this Purchase Order is not approved, The CCRMC Clinical Laboratory will not be able to perform patient testing for colorectal cancer. APPROVE OTHER RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE Action of Board On: 11/03/2015 APPROVED AS RECOMMENDED OTHER Clerks Notes: VOTE OF SUPERVISORS AYE:John Gioia, District I Supervisor Candace Andersen, District II Supervisor Mary N. Piepho, District III Supervisor Karen Mitchoff, District IV Supervisor Federal D. Glover, District V Supervisor Contact: Anna Roth, (925) 370-5101 I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown. ATTESTED: November 3, 2015 David Twa, County Administrator and Clerk of the Board of Supervisors By: June McHuen, Deputy cc: Tasha Scott, Crystal Grayson, N Rios C. 74 To:Board of Supervisors From:William Walker, M.D., Health Services Director Date:November 3, 2015 Contra Costa County Subject:Purchase Order with Polymedco Cancer Diagnostic Products, LLC CHILDREN'S IMPACT STATEMENT: Not applicable.